Correlation Between Amylyx Pharmaceuticals and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Cullinan Oncology LLC, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Cullinan Oncology.
Diversification Opportunities for Amylyx Pharmaceuticals and Cullinan Oncology
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Amylyx and Cullinan is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Amylyx Pharmaceuticals and Cullinan Oncology
Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 1.37 times more return on investment than Cullinan Oncology. However, Amylyx Pharmaceuticals is 1.37 times more volatile than Cullinan Oncology LLC. It trades about 0.19 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.11 per unit of risk. If you would invest 171.00 in Amylyx Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 348.00 from holding Amylyx Pharmaceuticals or generate 203.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amylyx Pharmaceuticals vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Amylyx Pharmaceuticals |
| Cullinan Oncology LLC |
Amylyx Pharmaceuticals and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amylyx Pharmaceuticals and Cullinan Oncology
The main advantage of trading using opposite Amylyx Pharmaceuticals and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |